Lucintel Forecasts the Global Cancer Immunotherapy Market to Reach $162.4 billion by 2030

CITY, Country, 2024-Apr-22 — /EPR Network/ —

According to a market report by Lucintel, the future of the global cancer immunotherapy market looks promising with opportunities in the hospital, cancer research center, and clinic markets. The global cancer immunotherapy market is expected to reach an estimated $162.4 billion by 2030 with a CAGR of 10.4% from 2024 to 2030. The major drivers for this market are rising incidence of cancer conditions, introduction of biosimilars, and growing demand for mAbs.

A more than 150 – page report is developed to understand Trends, opportunity and forecast in cancer immunotherapy market to 2030 by technology type (monoclonal antibodies, cytokines & immunomodulators, and others), application (lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head & neck cancer, and others), end use (hospitals, cancer research centers, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

In this market, lung, breast, colorectal, melanoma, prostate, and head & neck are the major segments of cancer immunotherapy market by application. Lucintel forecasts that lung will remain the largest segment over the forecast period.

Within this market, hospital will remain the largest segment over the forecast period.

Download sample by clicking on cancer immunotherapy market

North America will remain the largest region over the forecast period.

Novartis, Merck KGaA, F. Hoffmann-La Roche, Bayer, Bristol-Myers Squibb, Astrazeneca, Johnson & Johnson, Eli Lily, Amgen, and Pfizer are the major suppliers in the cancer immunotherapy market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056

Explore Our Latest Publications

Nanobody Market in Canada

Remdesivir Market in Canada

Impregnating Resins Market in Canada

Starch Blended Biodegradable Polymer Market in Canada

Compounded Resins Market in Canada

Gum Rosin Market in Canada